T cell receptor (TCR) recognition of MHC class I variants

Intermolecular second-site reversion provides evidence for peptide/MHC conformational variation

Ruben Dyall, Daved H. Fremont, Stephen C. Jameson, Janko Nikolich-Zugich

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We investigated mechanistic differences in antigen presentation between murine MHC class I variants H-2Kb and H-2Kbm8 H-2Kbm8 differs from H- 2Kb by four residues at the floor of the peptide-binding site, affecting its B pocket which interacts with the second (P2) residue of the peptide. The rest of the molecule, including the T cell receptor (TCR)-contacting residues, is identical to H-2Kb. Due to this variation, CTLs that recognize the ovalbumin257-264 and HSV gB(498-505 peptides on H-2kb cannot recognize them on H-2Kbm8. This could be due to impaired peptide binding or an altered peptide:Kbm8 conformation. Peptide binding studies ruled out the first explanation. Molecular modeling indicated that the most obvious consequence of amino acid variation between peptide/H-2Kb and peptide/H-2Kbm8 complexes would be a loss of the conserved hydrogen bond network in the B pocket of the latter. This could cause conformational variation of bound peptides. Intermolecular second-site reversion was used to test this hypothesis: P2-substituted OVA and HSV peptides, engineered to restore the hydrogen bond network of the B pocket, were the only ones which restored CTL recognition. These results provide a molecular understanding of peptide/MHC conformational variation.

Original languageEnglish (US)
Pages (from-to)253-258
Number of pages6
JournalJournal of Experimental Medicine
Volume184
Issue number1
DOIs
StatePublished - Jul 1 1996
Externally publishedYes

Fingerprint

T-Cell Antigen Receptor
Peptides
Hydrogen
Antigen Presentation
Binding Sites
Amino Acids

ASJC Scopus subject areas

  • Immunology

Cite this

T cell receptor (TCR) recognition of MHC class I variants : Intermolecular second-site reversion provides evidence for peptide/MHC conformational variation. / Dyall, Ruben; Fremont, Daved H.; Jameson, Stephen C.; Nikolich-Zugich, Janko.

In: Journal of Experimental Medicine, Vol. 184, No. 1, 01.07.1996, p. 253-258.

Research output: Contribution to journalArticle

@article{80e8d08368324f00b3bef77839bebbbe,
title = "T cell receptor (TCR) recognition of MHC class I variants: Intermolecular second-site reversion provides evidence for peptide/MHC conformational variation",
abstract = "We investigated mechanistic differences in antigen presentation between murine MHC class I variants H-2Kb and H-2Kbm8 H-2Kbm8 differs from H- 2Kb by four residues at the floor of the peptide-binding site, affecting its B pocket which interacts with the second (P2) residue of the peptide. The rest of the molecule, including the T cell receptor (TCR)-contacting residues, is identical to H-2Kb. Due to this variation, CTLs that recognize the ovalbumin257-264 and HSV gB(498-505 peptides on H-2kb cannot recognize them on H-2Kbm8. This could be due to impaired peptide binding or an altered peptide:Kbm8 conformation. Peptide binding studies ruled out the first explanation. Molecular modeling indicated that the most obvious consequence of amino acid variation between peptide/H-2Kb and peptide/H-2Kbm8 complexes would be a loss of the conserved hydrogen bond network in the B pocket of the latter. This could cause conformational variation of bound peptides. Intermolecular second-site reversion was used to test this hypothesis: P2-substituted OVA and HSV peptides, engineered to restore the hydrogen bond network of the B pocket, were the only ones which restored CTL recognition. These results provide a molecular understanding of peptide/MHC conformational variation.",
author = "Ruben Dyall and Fremont, {Daved H.} and Jameson, {Stephen C.} and Janko Nikolich-Zugich",
year = "1996",
month = "7",
day = "1",
doi = "10.1084/jem.184.1.253",
language = "English (US)",
volume = "184",
pages = "253--258",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

TY - JOUR

T1 - T cell receptor (TCR) recognition of MHC class I variants

T2 - Intermolecular second-site reversion provides evidence for peptide/MHC conformational variation

AU - Dyall, Ruben

AU - Fremont, Daved H.

AU - Jameson, Stephen C.

AU - Nikolich-Zugich, Janko

PY - 1996/7/1

Y1 - 1996/7/1

N2 - We investigated mechanistic differences in antigen presentation between murine MHC class I variants H-2Kb and H-2Kbm8 H-2Kbm8 differs from H- 2Kb by four residues at the floor of the peptide-binding site, affecting its B pocket which interacts with the second (P2) residue of the peptide. The rest of the molecule, including the T cell receptor (TCR)-contacting residues, is identical to H-2Kb. Due to this variation, CTLs that recognize the ovalbumin257-264 and HSV gB(498-505 peptides on H-2kb cannot recognize them on H-2Kbm8. This could be due to impaired peptide binding or an altered peptide:Kbm8 conformation. Peptide binding studies ruled out the first explanation. Molecular modeling indicated that the most obvious consequence of amino acid variation between peptide/H-2Kb and peptide/H-2Kbm8 complexes would be a loss of the conserved hydrogen bond network in the B pocket of the latter. This could cause conformational variation of bound peptides. Intermolecular second-site reversion was used to test this hypothesis: P2-substituted OVA and HSV peptides, engineered to restore the hydrogen bond network of the B pocket, were the only ones which restored CTL recognition. These results provide a molecular understanding of peptide/MHC conformational variation.

AB - We investigated mechanistic differences in antigen presentation between murine MHC class I variants H-2Kb and H-2Kbm8 H-2Kbm8 differs from H- 2Kb by four residues at the floor of the peptide-binding site, affecting its B pocket which interacts with the second (P2) residue of the peptide. The rest of the molecule, including the T cell receptor (TCR)-contacting residues, is identical to H-2Kb. Due to this variation, CTLs that recognize the ovalbumin257-264 and HSV gB(498-505 peptides on H-2kb cannot recognize them on H-2Kbm8. This could be due to impaired peptide binding or an altered peptide:Kbm8 conformation. Peptide binding studies ruled out the first explanation. Molecular modeling indicated that the most obvious consequence of amino acid variation between peptide/H-2Kb and peptide/H-2Kbm8 complexes would be a loss of the conserved hydrogen bond network in the B pocket of the latter. This could cause conformational variation of bound peptides. Intermolecular second-site reversion was used to test this hypothesis: P2-substituted OVA and HSV peptides, engineered to restore the hydrogen bond network of the B pocket, were the only ones which restored CTL recognition. These results provide a molecular understanding of peptide/MHC conformational variation.

UR - http://www.scopus.com/inward/record.url?scp=0030018187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030018187&partnerID=8YFLogxK

U2 - 10.1084/jem.184.1.253

DO - 10.1084/jem.184.1.253

M3 - Article

VL - 184

SP - 253

EP - 258

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -